SUMMARY
Dormant hematopoietic stem cells (dHSCs) are atop the hematopoietic hierarchy. The molecular identity of dHSCs and the mechanisms regulating their maintenance or exit from dormancy remain uncertain. Here, we use single-cell RNA sequencing (RNAseq) analysis to show that the transition from dormancy toward cell-cycle entry is a continuous developmental path associated with upregulation of biosynthetic processes rather than a stepwise progression. In addition, low Myc levels and high expression of a retinoic acid program are characteristic for dHSCs. To follow the behavior of dHSCs in situ, a Gprc5c-controlled reporter mouse was established. Treatment with all-trans retinoic acid antagonizes stress-induced activation of dHSCs by restricting protein translation and levels of reactive oxygen species (ROS) and Myc. Mice maintained on a vitamin A-free diet lose HSCs and show a disrupted re-entry into dormancy after exposure to inflammatory stress stimuli. Our results highlight the impact of dietary vitamin A on the regulation of cellcycle-mediated stem cell plasticity.
INTRODUCTION
Hematopoietic stem cells (HSCs) are unique in their capacity to self-renew and replenish the entire blood system upon transplantation in a serial manner (Seita and Weissman, 2010; Till and McCulloch, 1961) . HSCs give rise to a pool of multipotent progenitors (MPPs), which generate lineage-restricted progenitors, and finally, mature effector cells (Graf and Enver, 2009 ). We and others have recently identified a sub-population of HSCs by long-term label-retaining cell (LRC) assays, which are characterized by an extremely low in vivo proliferation history with only approximately five cell divisions per lifetime in a healthy mouse as shown by mathematical modeling (van der Wath et al., 2009; Wilson et al., 2008) . These so-called dormant HSCs HSCs ($700 cells out of 100 million hematopoietic cells in the murine bone marrow) but harbor the highest long-term reconstitution potential (summarized in Figure 1A ) (Bernitz et al., 2016; Qiu et al., 2014; Takizawa et al., 2011; Wilson et al., 2008) . dHSCs are reversibly activated in response to stress signals such as interferons, lipopolysaccharide (LPS), or chemotherapy and are of critical importance in the repair processes activated in response to bacterial/viral infections or after severe bleeding (Baldridge et al., 2010; Essers et al., 2009; Walter et al., 2015) . dHSCs progress to active HSCs (aHSCs), which comprise $70%-80% of the HSC pool, are slowly dividing, and harbor a reduced reconstitution potential (Wilson et al., 2008) . To date, the molecular fingerprint of HSC dormancy at the population and single-cell level, as well as the mechanism controlling their reversible cycle between dormant and active states during homeostasis and stress, remains largely unresolved. We have recently reported that retinoic acid (RA) metabolism is molecularly enriched in HSCs compared to downstream multipotent progenitor populations (Cabezas-Wallscheid et al., 2014). RA signaling has been shown to affect embryonic hematopoiesis and leukemogenesis (Chanda et al., 2013; Collins, 2008) . However, its role in hematopoietic stem/progenitor biology remains controversial (Chute et al., 2006; Ghiaur et al., 2013; Purton et al., 1999 Purton et al., , 2000 . RA is produced by two sequential oxidation steps from dietary vitamin A (Tang and Gudas, 2011) . Vitamin A is an essential nutrient required for the normal function of the visual system, growth and development, and maintenance of epithelial cellular integrity, immune function, and reproduction (Brown and Noelle, 2015; Mora et al., 2008) . Lack of vitamin A is common in pre-school children, associated with night blindness as well as in skin and immune system deficiencies (Brown and Noelle, 2015; Mora et al., 2008; Wagner, 1940) . Although the consequences of a vitamin A-free diet have been extensively studied in the context of the immune system (Brown and Noelle, 2015; Mora et al., 2008) , the specific relevance of vitamin A for the maintenance and function of HSCs is unresolved.
RESULTS

Whole-Transcriptome Analysis of Dormant HSCs
To establish a global molecular dormancy signature, we performed whole-transcriptome (RNA sequencing [RNA-seq] ) analysis of dHSCs (LRCs), aHSCs (non-LRCs), and multipotent progenitors 1 (MPP1; Figures 1A-1C , S1A, and S1B). Briefly, we used fluorescence-activated cell sorting (FACS)-sorted dHSCs, See also Figure S1 and Table S1 .
aHSCs, and MPP1 from SCL-tTA;H2B-GFP mice (hereafter termed SCL) chased for 150 days with doxycycline (DOX) ( Figure S1A ) (Wilson et al., 2008) and generated RNA-seq data as previously described ( Figure S1B ) (Cabezas-Wallscheid et al., 2014; Klimmeck et al., 2014) . We identified a set of 27,236 expressed genes including protein-coding genes, pseudogenes, and long non-coding RNAs ( Figure S1C ; Table  S1 ). Principle component analysis (PCA) showed a closer relationship between dHSCs and aHSCs compared to either one to MPP1 ( Figure S1D ). Consistently, we observed a large number of differentially expressed genes between MPP1 and either of the two HSC populations (false discovery rate [FDR] <0.1; Figure 1D ). These results indicate that the transcriptomes of dHSCs and aHSCs are more similar to each other than to MPP1.
Dormant HSCs Exhibit Low Expression of Essential Biosynthetic Processes
Consistent with our previous reports, Cyld expression was higher and Cd34 levels were lower in dHSCs, as confirmed by qPCR (Figures 1E and S1E) (Tesio et al., 2015; Wilson et al., 2008) . Other reported HSC markers, such as Sca-1 and Epcr/ Procr, or the recently described MolO stem cell signature (Figures 1E and S1F) (Wilson et al., 2015) were also higher expressed in dHSCs compared to aHSCs and MPP1. Moreover, the long non-coding RNA Meg3 was expressed specifically in dHSCs, while Pf4 and Myc become upregulated in aHSCs and MPP1 (Figures 1E and S1E) . Next, we investigated biological pathways differentially represented between dHSCs, aHSCs, and MPP1 using a competitive pathway enrichment analysis (Figures 1F, 1G , and S1G; FDR <0.1). dHSCs were molecularly enriched in immune-related processes such as chemokine signaling pathway, consistent with a likely immune protection of dHSCs against pathogens ( Figure 1F ). Peptide GPCRs and prostaglandin synthesis and regulation were also enriched in dHSCs ( Figure 1F ). By contrast, we found a robust downregulation of essential biosynthetic processes such as mRNA processing, eukaryotic transcription initiation, and translation factors in dHSCs compared to aHSCs and MPP1 ( Figure 1G ). This was associated with the downregulation of Myc target genes in dHSCs (FDR <0.1; Figure S1G ). These results suggest that reduced biosynthetic activity and a specific immune protection program distinguish dHSCs from the quiescent aHSCs.
Transition from dHSCs to aHSCs Occurs Gradually Next, we applied single-cell (SiC) RNA-seq to 384 dHSCs and HSCs (HSCs = dHSCs plus aHSCs). We FACS-purified dHSCs or HSCs from SCL mice chased for 150 days with DOX in six independent experiments . Interestingly, when visualizing the set of 319 SiCs that passed quality controls using clustering methods such as a hierarchical clustering heatmap, two-dimensional t-SNE representations, and PCA, we found no evidence for distinct clusters (Figures S2D-S2F ; STAR Methods). Thus, we hypothesized that the transition from dormant toward active HSCs follows gradual changes through a series of intermediate cellular states rather than by a binary switch on/off pattern. We then used a computational approach based on pseudo-time analysis (Haghverdi et al., 2016) together with diffusion maps to establish an order of the cells (see the STAR Methods). This revealed dHSCs at the right end of the diffusion map and active HSCs at the left end of the map ( Figure S2G ) (Haghverdi et al., 2015) . We next subdivided cells into four stages (1-4) based on their pseudotime ( Figure 2C ). dHSCs were most strongly enriched in early stages 1 and 2, while the majority of HSCs occurred in late stages 3 and 4, in line with the notion that these represent predominantly aHSCs. We also observed similar topology and ordering when analyzing the unseparated HSC population only (excluding sorted dHSCs), strongly suggesting that the established organization captures the transition from dHSCs to aHSCs ( Figure S2H ). We next quantified the activity of different pathways and assessed variation across the four stages FDR <0.1) . This analysis revealed 19 differentially regulated processes, the majority of which (15/19) exhibited patterns of gradually increased activity from dHSC stage 1 toward aHSC stage 4 cells . These included pathways associated with different cellular biosynthetic activities (such as mRNA processing and translation factors) ( Figures 2D  and S2I ), but also processes such as cell cycle-related pathways (DNA replication, G1 to S cell-cycle control) ( Figure S2J ) and tumor necrosis factor alpha (TNF-a) nuclear factor kB (NF-kB) signaling ( Figure S2K ). Confirmatory, the recently described MolO stem cell signature (Wilson et al., 2015) showed increased expression from the most dormant toward the most active HSCs ( Figures 2E and 2F ). Finally, three pathways, such as type II interferon and inflammatory signaling, did not show a continuous increase or decrease suggesting that these processes might act similarly in dormant and aHSCs ( Figure S2L ). Together, these results indicate that the global transition from inactive dHSCs (stage 1) to aHSCs (stage 4) can be best described by a continuous stream-like progression of steadily increasing metabolic activity and preparation for cell-cycle entry without the apparent presence of accumulating cellular intermediates.
Active HSCs Are Quiescent but Cell-Cycle Primed
To identify individual drivers of variability from dHSCs toward aHSCs, we performed a PCA analysis on all variable genes. We then used different maps to visualize both genes driving differences in PC-1 (e.g., Ly6a, Cdk6; Figure S2N ; for PCA see Figure S2D ) and, in addition, canonical marker genes (e.g., Myc; Table S2 ). While Egr1, Ifitm1, and Ly6a expression are steadily decreasing, Cdk4, Cdk6, and Myc expression are steadily increasing at the single-cell level during the transition toward aHSCs (Figures 2G and 2H) . Because genes driving differences in PC-1 were mainly cell-cycle activators such as Cdk6 and Nap1l1 ( Figure S2N ), we bioinformatically assessed the cell-cycle signature and cell-cycle stage of each individual cell ( Figures 2I-2K , S2O, and S2P) (Scialdone et al., 2015) . Consistent with the notion that both dormant and active HSCs are quiescent, all cells were classified as G 0 /G 1 . Similarly, the distribution of the probability for being in the G 0 /G 1 phase was comparable across stages of pseudo-time ( Figure S2O ). Next, to investigate evidence for subtle variations in cell-cycle stages between dHSCs and aHSCs, we applied PCA to a set of genes that are annotated to cell cycle finding higher expression of cell-cycle genes in stage 4 aHSCs ( Figures 2J, 2K , and S2P). We investigated individual members of the cell-cycle pathway in greater detail using population RNA-seq data of dHSC, aHSC, and MPP1 ( Figure S2Q ; Table S1 ). In line with the global Cyclone approach ( Figure 2I ), most genes related to DNA replication (Cdc45, Mcm4) were similarly low in dHSCs and aHSCs. In contrast, p57 was higher in dHSCs compared to aHSCs and MPP1, while Cdk4 increased its expression in aHSC and MPP1. These observations show that while dHSCs and aHSCs are both quiescent (both G 0 /G 1 ), aHSCs are cell-cycle primed and major regulators that are differentially expressed in dormant and active HSCs may be involved in retaining HSCs dormancy.
As Cdk6 protein expression has recently been linked to a quiescent state primed to cell-cycle entry (Laurenti et al., 2015) , we investigated its expression in dHSCs, aHSCs, and MPP1 by immunofluorescence ( Figures 2L and 2M ). Briefly, we scanned Cdk6 expression in 89 FACS-sorted single cells by confocal microscopy, generated 3D images, and quantified the volume of protein signal. Cdk6 expression was homogeneously very low in dHSCs, while individual cells within the aHSC and MPP1 population expressed higher Cdk6 levels. In addition, overall levels of Cdk6 steadily increase from dHSCs to aHSCs and MPP1 (Figures 2L and 2M) in line with studies in human long-term and short-term HSCs (Laurenti et al., 2015) .
To functionally explore the differences in the cell-cycle entry kinetics between the dormant and the active/quiescent state, we performed SiC in vitro tracking analysis ( Figures  2N and 2O ) (Haetscher et al., 2015; Rieger et al., 2009 ). We FACS-sorted dHSCs and aHSCs and calculated the time to first division of 285 SiCs by live cell imaging. Interestingly, aHSCs showed an average of 29.5 ± 0.7 hr to generate the first progeny, while dHSCs needed 40.8 ± 1.3 hr. This pronounced difference (11.3 hr) between two initially non-cycling populations suggests that dHSCs reside in a deeper level of quiescence.
Altogether, these results show that protein synthesis and cellcycle-related components increase in HSCs exiting dormancy and moving toward the active state. Although aHSCs have not yet entered the cell cycle and thus are still considered quiescent, they are already primed toward more active metabolic and cellcycle-related pathways.
Isolation of Viable dHSCs Using the Gprc5c-EGFP Reporter Mouse
So far, reliable identification and ex vivo isolation of dHSCs has been only possible using time-consuming LRC assays performed in inducible H2B-GFP expressing mouse lines by labeling cells with bromodeoxyuridine (BrdU) or Carboxyfluorescein succinimidyl ester (CFSE) (Bernitz et al., 2016; Foudi et al., 2009; Qiu et al., 2014; Takizawa et al., 2011; Wilson et al., 2008) . Because several mouse models enabling HSC identification have recently been generated (Acar et al., 2015; Chen et al., 2016; Gazit et al., 2014a) , we first investigated whether their expression is also specific for dHSCs ( Figure S3A ). Although the expression of all the reported HSC markers is higher in HSC and HSC-MPP1 compared to late MPPs, none of them has a robust differential expression in dHSCs. Thus, to identify dHSC-specific cell surface markers, we searched our RNA-seq expression data (dHSC versus aHSCs) and classified all expressed genes enriched in dHSCs according to their protein class (FDR <0.1; Figure S3B ). Among other receptors and cell adhesion molecules, the surface receptor, Gprc5c (G protein-coupled receptor, class C, group 5; retinoic acidinduced gene 3 [Raig3]) was higher expressed in dHSCs compared to aHSCs and MPP1 ( Figure 3A ). Gprc5c encodes an orphan G protein-coupled receptor (Robbins et al., 2000) that activates intracellular heterotrimeric G proteins (Pierce et al., 2002) . Expression analysis including the MPP1-MPP4 subsets confirmed its low expression in early progenitors as shown by RNA-seq ( Figure 3B ) (Cabezas-Wallscheid et al., 2014) and qPCR ( Figure S3C ). To corroborate and extend these findings, we employed a bacterial artificial chromosome (BAC) transgenic reporter mouse line expressing EGFP under the control of the Gprc5c promoter (Gprc5c-EGFP) ( Figure 3C ; STAR Methods). We characterized the activity of the Gprc5c promoter in the HSC-MPP compartment by measuring EGFP expression (Figures 3D, S3D, and S3E) . In line with the presence of 20%-30% of dHSCs within the adult HSC compartment and our RNA expression profiles ( Figure 1A ) (van der Wath et al., 2009; Wilson et al., 2008) , we observed that 27.9% ± 8.1% of all HSCs expressed EGFP under the control of the Gprc5c promoter (hereafter named Gpr pos ). In contrast, only 3.0% ± 1.8% of MPP1 and 1.6% ± 0.3% of other MPPs were Gpr pos . In agreement with data linking higher CD150 expression to increased HSC Figure 3J ) and SiC in vitro tracking assays ( Figure 3K ) showed that HSC-Gpr pos are more quiescent and require more time for their first division compared to HSCsGpr neg cells. Serial colony-forming unit (CFU) assays and transplant experiments ( Figures 3L-3O) showed that HSCs-Gpr pos formed significantly more colonies than HSCs-Gpr neg cells in secondary platings ( Figure 3M ) and an improved outcome in secondary transplantations compared to HSCs-Gpr neg transplanted animals indicating higher self-renewal capacities ( Figure 3N ). HSCs-Gpr pos were multipotent giving rise to myeloid and lymphoid lineages ( Figures 3O and S3K ). To functionally validate HSC-Gpr pos cells as a reversible dHSC population in vivo, we stimulated Gprc5c-EGFP mice with the double-stranded RNA analog polyI:polyC (pIC) mimicking viral infection and measured EGFP expression 16 hr and 8 days after stimulation ( Figure 3P ) (Essers et al., 2009) . The proportion of HSC-Gpr pos cells decreased from 20.5% ± 2.2% during homeostatic conditions to 6.2% ± 1.4% 16 hr after pIC treatment (see also Figure S3L ), but returned to initial levels (28.8% ± 3.5%) after a recovery period of 8 days. To address the behavior of dHSCs upon serial stress stimulation, we serially treated Gpr-EGFP mice with pIC and measured the HSC-Gpr pos levels 4 weeks after stimulation ( Figures 3Q, S3M , and S3N). We found that the HSC-Gpr pos compartment was reduced compared to the PBS-treated group suggesting incomplete recovery of dHSCs after long-term stress stimulation. Taken together, these results show that HSC-Gpr pos cells display similar molecular and functional properties as dHSCs, demonstrating that the Gprc5c-EGFP reporter mouse line is a valid alternative tool to track dHSCs and thus circumvent LRC assays. In addition, the reversibility of the Gprc5c-EGFP system allows a flexible analysis of the dHSC compartment in homeostatic and stress-induced settings.
All-trans Retinoic Acid Treatment Maintains dHSCs In Vitro
By examining our RNA-seq dataset, we found that retinoic acid (RA)-induced signaling was highly enriched in dHSCs compared to aHSCs and MPP1 ( Figures 4A and 4B ), confirming and extending our recent findings on HSC-MPPs (Cabezas-Wallscheid et al., 2014) ( Figure S4A ). To functionally address the role of RA signaling in dHSCs, we cultured hematopoietic stem/progenitor cells (HSPCs) isolated from Gpr-EGFP mice with activating conditions in the presence or absence of the RA signaling agonist all-trans retinoic acid (ATRA). ATRA-treated HSCs showed significantly higher retention of EGFP levels (measure of dormancy) compared to untreated conditions ( Figures 4C, 4D , S4B, and S4C). Cell viability upon ATRA treatment was unaffected in HSCs as shown by measurement of active caspase-3 ( Figure S4D ). In agreement, maintenance of dHSC/LRCs (GFP + cells) isolated from SCLtTA;H2B-GFP mice DOX-chased for 150 days was enhanced, and cells remained in a GFP + state in the presence of ATRA in vitro ( Figure S4E ). Cell-cycle profiles measured by Hoechst/ Ki67 staining revealed that HSCs cultured with ATRA were significantly more quiescent (Figures 4E and S4F) . To assess whether the observed cell-cycle phenotype is dependent on other progenitor cells, we FACS-sorted phenotypic HSCs and cultured them with ATRA ( Figure S4G ). Purified ATRA-treated HSCs exhibited a cell-cycle arrest, indicating a cell-autonomous effect. An overall low biosynthetic activity was a major difference between the transcriptional profile of dHSCs and their progeny ( Figure 1G ). To evaluate whether RA signaling has an effect on translation, we used a membrane-diffusible alkaline analog of puromycin, O-propargyl-puromycin (OP-Puro) to explore de novo protein synthesis (Liu et al., 2012; Signer et al., 2014) . We observed a 24% decrease in OP-Puro incorporation in ATRAtreated HSCs, suggesting lower nascent protein translation rates upon active RA signaling ( Figure 4F ). Low levels of reactive oxygen species (ROS) linked to low use of oxidative phosphorylation as an energy source have also been associated with homeostatic HSC quiescence (Ludin et al., 2014; Suda et al., 2011) . To quantify relative differences in ROS levels in intact living cells, we employed transgenic mice globally expressing mitoroGFP2-Orp1 (Fujikawa et al., 2016), a genetically encoded H 2 O 2 -sensitive probe targeted to the mitochondrial matrix (Figures 4G and S4H) . Strikingly, we observed a strong reduction of the mitochondrial sensor upon ATRA treatment, back to a level similar to the ex vivo uncultured samples (Figures 4G and S4H) . Taken together, these results show that RA signaling retains HSC quiescence in activating cell culture conditions by maintaining low translation rates and preventing increase of ROS.
ATRA-treated HSCs mimicked a dormant state recently described in Myc-depleted embryonic stem cells, characterized by low proliferation and biosynthesis (Scognamiglio et al., 2016) . In line, c-Myc levels were low in dHSCs but increased in aHSCs ( Figure 2H ). Thus, we cultured HSPCs from Gpr-EGFP mice with the Myc/Max inhibitor 10058-F4 (Zirath et al., 2013) . We found slightly higher numbers of HSC-Gpr pos retained in a more quiescent state, partially mimicking the effects of ATRA ( Figure 4H ). To address whether c-Myc protein is regulated by RA signaling, we used the c-Myc-GFP reporter mouse model ( Figure 4I ) (Huang et al., 2008) . ATRA treatment significantly attenuated the c-Myc-GFP upregulation upon culture, and this effect was not synergistic as shown by combining ATRA and MYCi treatments ( Figure S4I ). In summary, our results show that ATRA treatment retains low levels of c-Myc, and inhibition of Myc activity partially mimics the preservation of dormancy by ATRA, indicating that ATRA may preserve dormancy by restricting Myc.
To assess the preservation of molecular fingerprints of HSCs, we addressed differential expression signatures upon in vitro ATRA treatment and compared these to non-cultured HSCs (0 hr) as well as in vivo stressed-HSCs (16 hr after a single pIC injection) (Figures 4J, S4K, and S4L; Table S3 ). As expected, target genes of the RA pathway such as Tgm2, Rbp1, and Gprc5c were upregulated or maintained upon ATRA treatment compared to the in vitro control and the stressed in vivo group ( Figure 4J ). In accordance with the observed cell-cycle arrest ( Figure 4E ), Cdk6 expression was reduced in ATRA-treated cells, while the self-renewal-associated Hoxb4 gene (Antonchuk et al., 2001) was maintained in response to ATRA. Rarg was downregulated in ATRA-and non-ATRA-treated HSCs while Rara was not detected (data not shown). In contrast, Rarb expression was entirely depleted in control samples but maintained at physiological levels upon ATRA treatment. These data were supported by our RNA-seq expression analysis, showing that the Rarb receptor (in contrast to Rarg and Rara) is specifically expressed in dHSCs compared to aHSCs and MPP1 ( Figure S4J ). Further, microarray-based global transcriptome analysis showed that ATRA-treated cells presented a robust downregulation of G2M checkpoints, E2F targets, ROS species, and Myc targets compared to untreated cells ( Figure S4L ), supporting our previous findings ( Figures 4C-4I ). Because Gprc5c-KO HSPCs do *p <0.05; **p <0.01; ***p <0.001. n.s., not significant. N indicates biological replicates. For all experiments greater than or equal to two independent experiments were performed unless otherwise indicated. See also Figure S4 and Table S3. respond to ATRA treatment, Gprc5c itself is not mediating the observed cell-cycle effects ( Figure S4M ). We next performed serial plating CFU assays and transplantation experiments (Figures 4K-4M ). ATRA-treated cells formed significantly more colonies in the second plating and also performed better in subsequent serial reconstitution experiments compared to control cells ( Figures 4L and 4M ). To address whether the observed effect is dHSC-specific, we cultured FACS-sorted HSCs-Gpr pos and HSCs-Gpr neg in the presence or absence of ATRA and performed CFU re-plating assays (Figure 4N ). ATRA treatment considerably increased the HSCGpr pos number of colonies in the secondary plating compared to both untreated and ATRA-treated HSCs-Gpr neg . These results argue for a distinct role of RA signaling in HSCs-Gpr pos cells and are in line with the molecular signatures, in vivo transplants, and in vitro CFU assays ( Figures 4K-4N ). Together, ATRA treatment retains the long-term self-renewal capabilities of dHSCs in vitro.
Because ATRA is the biologically active metabolite of vitamin A (retinol) (Collins, 2008), we next addressed whether HSCs are able to metabolize vitamin A-retinol. First, HSPCs were cultured with retinol and cell-cycle profiles were assessed ( Figures 4O  and S3N ). MPP2 and MPP3/4 did not display the expected cell-cycle arrest observed upon in vitro ATRA treatment suggesting that these populations are not able to metabolize retinol. By contrast, HSCs and MPP1 showed similar cell-cycle arrest as observed upon ATRA treatment. Next, we addressed whether the observed effect is dHSC-specific and cell-autonomous by culturing FACS-sorted HSCs-Gpr pos and HSCs-Gpr neg (Figure 4P) . HSCs-Gpr pos showed higher cell-cycle arrest compared to HSCs-Gpr neg in all conditions.
Collectively, these data show that ectopic RA signaling can maintain HSC quiescence even in activating culture conditions by retaining low translation, proliferation, ROS levels and c-Myc protein levels. Moreover, external vitamin A-retinol can be metabolized by dHSCs in a cell-autonomous manner.
ATRA Treatment Retains Dormancy and Reduced Levels of ROS in Response to Stress-Mediated Activation Signals In Vivo
Based on the results above, we hypothesized that activation of HSCs in vivo with treatments such as pIC should lead to downregulation of RA signaling. We treated mice with PBS or pIC and 16 hr later FACS-sorted HSCs and performed transcriptome analysis (hereafter termed HSCs-Control and HSCs-pIC, respectively) (Figures 5A and 5B; Table S4 ). Most of the RAinduced genes were downregulated upon pIC treatment. Next, we pre-treated either Gpr-EGFP or mito-roGFP2-Orp1 mice with ATRA followed by a single pIC injection to investigate whether ATRA pre-treatment would prevent dHSCs from cellcycle entry ( Figure 5C ). Neither the percentage of HSC-Gpr pos cells nor cell-cycle profiles were changed by short-term ATRA treatment during homeostasis ( Figures 5D and 5E ). As expected, we observed an induction of Sca-1 expression within the LSK population after pIC injections in control and ATRA-treated groups ( Figures S5A and S5B ) (Essers et al., 2009 ). In contrast, ATRA pre-treatment caused a preservation of HSC-Gpr pos cells in response to pIC treatment ( Figure 5D ). In agreement, ATRAtreated HSCs were kept in a more quiescent G 0 state as determined by cell-cycle analysis (Figures 5E and S5A) . Of note, this was not observed in MPPs indicating that ATRA-mediated effects are HSC-specific and no changes in HSC-MPP frequencies were observed ( Figures S5C and S5D ). Furthermore, HSCs from ATRA-treated mice showed a lower degree of oxidation upon exposure to stress stimuli ( Figure 5F ). Next, we performed microarray-based transcriptome analysis on HSCs isolated from pretreated ATRA mice followed by pIC injection (hereafter termed HSCs-ATRA and HSCs-ATRA-pIC, respectively) ( Figure 5G ; Table S4 ) and compared their transcriptome to HSCs-Control and HSCs-pIC ( Figures 5A, 5H , and S5E). HSCs-Control and HSCs-ATRA were transcriptionally similar (10 differentially expressed genes [DEG] ; Figures 5H and 5I) in line with our previous observation on unchanged HSC-Gpr pos numbers and cell-cycle profiles ( Figures 5D and 5E ). As expected, HSCs-Control and HSCs-pIC showed robust transcriptional differences (3,414 DEG). Strikingly, these differences were strongly reduced when comparing HSCs-Control to HSCs-ATRA-pIC (684 DEG). RA target genes ( Figure 5J ) and global processes (cell cycle, developmental processes; FDR <0.1; Figures 5K and 5L) were partially rescued by ATRA pre-treatment. GSEA analysis revealed a significant downregulation of Myc targets, G2M checkpoint, and an upregulation of RA-induced signaling in HSCs-ATRA-pIC compared to HSCs-pIC ( Figure S5F ). Next, we performed CFU , ±SEM is shown. *p <0.05; **p <0.01; ***p <0.001. n.s., not significant. N indicates biological replicates. For all experiments, greater than or equal to two independent experiments were performed unless otherwise indicated. See also Figure S5 and Table S4. assays and found that ATRA treatment did not alter the number of colonies in pIC-untreated cells but it partially rescued the decreased CFU activity of pIC-treated mice ( Figure 5M ). In summary, the presence of ATRA attenuates pIC-induced HSC activation in vivo.
To investigate whether the retention of ATRA-treated HSCs in dormancy is expandable to other HSC-activation regimen, we treated mice with bacterial liposaccharide (LPS) (Takizawa et al., 2011) (Figures 5N-5P and S5G ). Also upon LPS stimulation, ATRA pre-treatment maintained HSC-Gpr pos cells (Figure 5O ). In line, HSCs pre-treated with ATRA were maintained in a more quiescent state, and this difference was not observed in MPPs (Figures 5P and S5G ). Further, we employed the chemotherapeutic agent 5-fluorouracil (5-FU) to activate HSCs ( Figures  5Q, S5H , and S5I) (Venezia et al., 2004) . Strikingly, upon 5-FU treatment and in the presence of ATRA, HSCs were retained in a more quiescent state compared to the control group, and this effect was not observed in MPPs. These results demonstrate that RA signaling specifically retains HSC quiescence in mice exposed to diverse HSC activation conditions, including pIC, LPS, and the chemotherapeutic agent 5-FU, and illustrates the potency of RA/vitamin A to prevent cycling and thus maintenance of functional quiescent HSCs not only in culture but also in vivo.
Vitamin A-free Diet Leads to Impaired dHSC Reversibility To address whether vitamin A-mediated RA signaling is required for HSCs, we fed adult mice with a vitamin A-free diet for 14-17 weeks (hereafter termed vit.A-free; Figure 6A ) to deplete the RA reservoir in vivo. White blood cell and lymphocyte counts progressively decreased in vit.A-free mice ( Figures 6B and S6A ). Body weight and spleen/body ratios were unchanged ( Figures S6B and S6C ), while bone marrow (BM) cellularity was reduced ( Figure S6D ). In addition, BM granulocytes were slightly increased, mature B cells were significantly reduced, and splenic LSK frequencies remained unchanged ( Figures S6E and S6F ). HSC frequency in the bone marrow was significantly decreased ( Figure 6C ). Similarly, the number of dormant HSC-Gpr pos cells were significantly reduced in a homeostatic vit.A-free environment (Figure 6D) . Cell-cycle analysis showed no significant difference between the groups ( Figure 6E ). However, qPCR analysis of HSCs from vitamin A-starved mice showed downregulation of Rarb and Cyp26b1 expression while other RA target genes (e.g., Rbp1, Cdk6, and Hoxb4) did not change in HSCs nor in MPPs ( Figure 6F ). Serial CFU assays of vit.Afree BM cells showed decreased number of colonies in serial platings indicating defective long-term self-renewal (third, fourth plating; Figure 6G ). In addition, upon transplantation of vit.A-starved bone marrow, the reconstitution potential was decreased suggesting functional impairment of HSCs present in the bone marrow of mice suffering from vit.A-starvation ( Figure 6H ). Next, we assessed reversibility of dHSCs in a normal and a vit.A-free environment by applying a single pIC injection 8-11 days before analysis ( Figures 6I-6L and S6H-S6L). As expected, HSCs in a control environment returned to similar HSC numbers and to a quiescent state 8-11 days after pIC treatment ( Figures 6J and 6K ). In contrast, HSCs in a vit.A-free environment showed an impaired recovery of the quiescent state as shown by further reduced HSC frequencies and delayed return to G 0 (Figures 6J and  6K) . Strikingly, HSC-Gpr pos cells were not regenerated at this point after pIC-mediated activation in the absence of vitamin A ( Figure 6L ). Collectively, these data strongly suggest that vitamin A is required to maintain a potent HSC pool and to re-establish dHSCs during the recovery phase after pIC stimulation.
DISCUSSION
In agreement with their biological behavior, we now show by single-cell RNA-seq analysis that dHSCs harbor an extremely low overall biosynthetic activity. These biosynthetic processes gradually increase toward aHSCs indicating that the transition from dHSC to aHSCs can be better described as a continuously changing cellular state rather than the anticipated stepwise switch from one cell type to the next. The fact that numerous intermediate states are found may reflect the response to latent minor acute inflammatory events or result from stress responses that occurred in the past. For example, muscle stem cells show a transition from a G 0 to a G alert state, which may represent a similar situation (Rodgers et al., 2014) . The difference in the overall biosynthetic activity provides a valid explanation why dHSCs need $11 hr longer to initiate their first productive cell cycle compared to aHSCs, which are themselves still in a non-cycling quiescent state. These data demonstrate the functional and molecular difference between: quiescent aHSCs (higher biosynthetic activity, cell-cycle primed/quick return into S-phase [G 0 /G 1 ], RA-signature low ) and deeply dormant dHSCs (low biosynthetic activity, slow return into S-phase [G 0 only], RA-signature high ). The re-entry of dHSCs into the cell cycle is accompanied by the downregulation of p57 and the upregulation of the Cdk4/6 complex, both recently shown to play a crucial role in maintaining HSC quiescence and promoting initial HSC cell divisions, respectively (Laurenti et al., 2015; Matsumoto and Nakayama, 2013; Zou et al., 2011) . The coordination between biosynthetic activity and cell-cycle-related processes with consequences on HSC function and differentiation has also recently been observed in other stem cell systems (Rodgers et al., 2014; Sanchez et al., 2016) . For example, Drosophila germline stem cell differentiation relies on pathways promoting global protein synthesis (Sanchez et al., 2016) , and overall protein production appears to be critical for progenitors (Signer et al., 2014) . Low levels of Myc expression maintain naive embryonic stem cells (ESCs) and pre-implantation embryos in a dormant state of pluripotency (diapause) (Scognamiglio et al., 2016) likely mediated by the broad role of Myc in activating biosynthetic processes (Stine et al., 2015) . In agreement, we find Myc expression to be very low in dHSCs and to steadily increase during the transition toward aHSCs and subsequently MPP1-4 (Cabezas-Wallscheid et al., 2014; Ehninger et al., 2014; Laurenti et al., 2008) . In mice in which both Myc genes, c-Myc and N-Myc, have been deleted, only dHSCs survive, while all other hematopoietic cells are lost due to apoptosis, suggesting that only dHSCs are able to survive a completely Myc-deficient state (Laurenti et al., 2008 ). These For all panels, Control, mice on normal diet; Control recov., mice on normal diet 8 to 11 days after pIC injection; VitA-free, mice on vitamin A-free diet for 14-17 weeks; VitA-free recov., mice on vitamin A-free diet for 14-17 weeks after 8-11 days after pIC injection; ±SEM is shown. *p <0.05; **p <0.01; ***p <0.001. n.s., not significant. N indicates biological replicates. For all experiments, greater than or equal to two independent experiments were performed unless otherwise indicated. See also Figure S6 . data suggest that a threshold level of biosynthetic activity may be necessary for the initiation of differentiation of HSCs and possibly other stem cells, while low activity preserves stem cell potency and self-renewal potential.
Our transcriptome analysis revealed a highly significant enrichment of retinoic acid (RA)-induced target genes in dHSCs. Treatment of HSCs in vitro with the agonist all-trans retinoic acid (ATRA) induces cell-cycle arrest and inhibits proliferation, supporting previous observations (Jacobsen et al., 1994; Purton et al., 1999) . Importantly, we now show by in vitro and in vivo analysis, that ATRA treatment preserves dHSCs and maintains critical properties of HSCs under stress conditions. These include maintenance of long-term self-renewal, low proliferation associated with decreased Cdk6 levels, expression of key transcription factors (Hoxb4), reduced protein synthesis, and reactive oxygen species (ROS) generation as well as low Myc protein levels. However, ATRA treatment does not completely block HSC activation. Other pathways such as prostaglandin synthesis and regulation are also enriched in dHSCs and prostaglandin E2 (PGE2) has been shown to regulate HSC homeostasis (North et al., 2007) . Thus RA and prostaglandin pathways may cooperate to maintain adult HSCs under various conditions, a possibility that can now be investigated at the molecular and functional level. ATRA protects HSCs from entering the cell cycle upon diverse stress stimuli (pIC, LPS, 5-FU) in vivo. This effect on HSCs is opposite to what occurs in more differentiated blood cells and certain leukemias, in which ATRA typically displays pro-differentiation effects (Collins, 2008; Masetti et al., 2012) . This might be explained by cell-specific expression of the various RAR receptors. For example, ATRA plays a pro-differentiation role in acute promyelocytic leukemia harboring a promyelocytic leukemia (PML)-RARa translocation (Masetti et al., 2012) . Our transcriptome data show a low expression of Rara in the dHSC compartment. Indeed, PML leukemia-initiating cells (LIC) are established at the level of the granulocyte progenitor population with little resemblance to normal HSCs (Reinisch et al., 2016) . Future studies should explore the exact mechanism of the distinct effect of RA signaling in dormant mouse and human HSCs and more mature cell types and acute myeloid leukemia (AML)-LICs.
Most of the studies on vitamin A deficit-associated immunodeficiency are dedicated to the impaired function of lymphocytes (Brown and Noelle, 2015; Mora et al., 2008) . Our data obtained by analyzing mice fed with a vitamin A-deficient diet now extend the role of vitamin A-RA in the hematopoietic system to the regulation of HSCs in particular during inflammation-induced emergencies. These data were obtained using a systemic loss of vitamin A, and thus the effects could result from specific HSC autonomous and/or microenvironmental alterations. However, the following results argue that the vitamin A-deficient phenotype is caused, at least in part, by the impairment of the dHSC compartment: (1) dHSCs are characterized by a RA-signature high phenotype, which is (2) specifically and reversibly changed during the activation process; (3) dHSC metabolize vitamin A in a cell-autonomous manner; (4) vitamin A-free HSCs have a decreased long-term self-renewal capacity (5) and are unable to re-establish a normal dHSC compartment upon stress. Together, these data argue that differential regulation of RA signaling controls the reversible balance between dormancy and self-renewal, most evident during stress response. The failure to return to the dormant state in the vitamin A-deficient microenvironment likely primes HSCs toward an irreversible differentiation trajectory with associated loss of self-renewal and HSC exhaustion. Collectively, our study highlights the implications and consequences that the absence of vitamin A in the diet or as dietary supplements may have on stem cell function and possibly associated diseases.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Mice
The transgenic mouse line, SCL-tTA; H2B-GFP, which expresses the fusion protein histone H2B-GFP under the tetracycline-responsive regulatory element and the tTA-S2 transactivator from the endogenous SCL locus (Wilson et al., 2008) . Doxycycline was supplemented in drinking water of 8-12 weeks old mice for 150 days as previously described (Wilson et al., 2008) . Backcrossed to C57BL/6J. Gprc5c-EGFP. Tg(Gprc5c-EGFP)JU90Gsat. EGFP gene was inserted into a BAC clone at the initiating ATG codon of the first coding exon of the Gprc5c gene and this BAC clone was subsequently used to generate transgenic reporter mice (Gong et al., 2003) . Backcrossed to C57BL/6J. > 20-week old mice were used through the study (similar age as SCL-tTA;H2B-GFP at the time of analysis = 8-12 weeks + 150 days DOX) unless not otherwise specified. Myc-eGFP. Knockin mouse model that expresses a fusion protein of c-Myc and eGFP. c-MyceGFP/eGFP (Huang et al., 2008) . 8-12 weeks old mice were used through the study. Mito-roGFP2-Orp1. Mito-roGFP2-Orp1 expressing mice were generated as detailed in (Fujikawa et al., 2016) . 8-12 weeks old mice were used through the study. C57BL/6J. 8-to 20-week-old (CD45.2, CD45.1 or CD45.2/CD45.1) mice were either purchased from Harlan Laboratories (the Netherlands) or breed in-house. Gprc5c-KO. 8-to 12-week-old mice were used. Knockout mice were generated and described by (Sano et al., 2011) . All mice were bred in-house in the animal facility at the DKFZ under specific pathogen free (SPF) conditions in individually ventilated cages (IVC). According to German guidelines, mice were euthanized by cervical dislocation. Animal procedures were performed according to protocols approved by the German authorities, Regierungsprä sidium Karlsruhe (Nr. Z110/02, DKFZ 299, .
METHOD DETAILS
Cell suspensions and flow cytometry Mouse bone marrow (BM) cells were isolated, and dHSC, aHSC and MPP1 progenitors defined by immunophenotype (Lineage À Sca1 + Kit + CD150+ CD48-CD34+/À) and label-retention (for SCL-tTA;H2B-GFP) or EGFP signal (for Gprc5c-EGFP), or LSK were purified by FACS and subsequently subjected to population RNA-seq, in vitro tracking, CFU analysis or reconstitution assays. Briefly, BM was isolated from pooled femora, tibiae, ilia and vertebrae by gentle crushing in PBS 2%FCS using a mortar and pistil. Lysis of erythrocytes was performed using ACK Lysing Buffer (Thermo Fisher Scientific). To deplete lineage-positive cells we used the Dynabeads Untouched Mouse CD4 Cells Kit (Invitrogen). Briefly, total BM was stained for 30 min with a 1:5 dilution of the Lineage Cocktail provided in the Dynabeads Untouched Mouse CD4 Cells Kit (Invitrogen). Labeled cells were then incubated for 20 min with 1.5 mL/mouse of washed polyclonal sheep anti-rat IgG coated Dynabeads provided in the Kit. Cells were depleted using a magnet, enriching for the lineage-negative (Lineage Population RNA-seq Generation Population RNA-seq data were generated as previously described (Cabezas-Wallscheid et al., 2014; Klimmeck et al., 2014) . Briefly, total RNA isolation was performed using ARCTURUS PicoPure RNA Isolation Kit (Life Technologies, Invitrogen) according to the manufacturer's instructions. Total RNA was used for quality controls and for normalization of starting material. cDNA-libraries were generated with 1 ng of total RNA for dHSCs, aHSCs and MPP1 using the SMARTer Ultra Low RNA Kit for Illumina Sequencing (ClonTech) according to the manufacturer's indications. Sequencing was performed with the HiSeq2000 device (Illumina) using one sample per lane, resulting in between 272,204,749 and 457,840,113 reads per sample. Workflow and quality controls (QCs) summarized in Figures S1A and S1B. Low level processing Sequenced read fragments were mapped to the mouse reference genome GRCm38 (ENSEMBL release 69) using STAR (STAR_2.4.0h) (Dobin et al., 2013) . Expression counts estimates were generated using HTSeq (0.6.1) (Anders et al., 2015) . DESeq2 (Love et al., 2014) was used to test for differential expression; results were considered significant at an FDR < 0.1. Downstream analysis PCA visualization was performed based on variance stabilized read counts using the DESeq2 package (Love et al., 2014) . Differential expression analyses were performed using a Wald test to test for significance of coefficients in a Negative Binomial GLM with the DESeq2 package. We used CAMERA (Wu and Smyth, 2012) to test whether a set of genes annotated to pathways form WikiPathways (Kutmon et al., 2016) was highly ranked relative to other genes in terms of differential expression (Figures 1F and 1G ; FDR < 0.1).
Single-cell RNA-seq Generation Capture of single cells were performed using the C1 Auto-Prep 5-10mM Integrated Fluidic Chip (IFC) (Fluidigm) then imaged and annotated under bright field light microscopy using 20x objective to confirm single-cell capture. Cells captured alongside debris, doublet cells and dead cells were flagged for exclusion in downstream analysis. Subsequent reverse transcription and amplification of cDNA was performed on-chip using the Smarter Ultra Low RNA Kit (ClonTech) chemistry according to Fluidigm C1 protocol. Library prep for Illumina sequencing was carried out only on single-cells confirmed by microscopy using Nextera XT DNA Sample preparation kits (Illumina) 1.25 mL cDNA for each cell, tagmentation has been done according to the Fluidigm C1 protocol. Each Fluidigm IFC capture was pooled and sequenced over 2 lanes per pool on Illumina HiSeq 2500. ERCC (External RNA Controls Consortium) spike-in dilution 1:4000. Workflow and quality controls (QCs) summarized in Figure S2A . Low level processing Raw sequencing reads were mapped with STAR (STAR_2.4.0h) (Dobin et al., 2013) , using a custom reference containing both the reference mouse genome (GRCm38) along with ERCC sequences. Expression counts estimates were generated using HTSeq (0.6.1) (Anders et al., 2015) . Following the counting of mapped reads, we imposed additional quality control criteria to identify and remove low quality cells. Cells that did not pass all of the six following criteria were removed from the analysis: A set of 319 out of 384 cells passed all criteria, consisting of 173 HSCs and 146 dHSCs. We next performed size factor normalization using a standard DESeq size factor estimated from reads mapped to endogenous genes ( Figure S2) . To assess the effect of technical noise, we first used a log-linear fit to capture the relationship between mean and squared coefficient of variation (CV) of the log-transformed, size-factor normalized data (Brennecke et al., 2013) . We then considered genes with a squared CV greater than the estimated squared baseline CV as variable beyond technical noise. This filter for highly variable genes resulted in 4,707 genes, which were used for all downstream analyses. Quality controls To account for possible batch effects, we next applied scLVM (Buettner et al., 2015) (https://github.com/PMBio/scLVM) to regress out such batch effects, controlling for experimental design (cell type). Covariance matrices for batch as well as cell type were modeled using a delta kernel (dummy coding the batches) and treated as random effects. As quality control that batch effects were accounted for we used a 2D PCA of the residual expression values. After batch correction, we found that dHSCs (146 SiCs from three plates) mixed across plates and also occurred in HSCs (173 SiCs from three plates; Figure S2C ). Single-cell RNA-seq data analysis All analyses were performed based on the normalized and batch corrected expression data of the 4,707 variable genes.
Visualization and clustering
To visualize single cells and to explore the presence of possible sub-populations, we first generated a 2D heatmap using all 319 dHSCs and HSCs (using the R package gplots), and we applied PCA as well as a t-SNE to visualize the cells using 2D coordinates (van der Maaten and Hinton, 2008); using R package Rtsne). None of these approaches suggested that there is a discrete structure ( Figures S2D-S2F ). Since no distinct clusters were present in the tSNE and heatmap-based clustering analyses we used diffusion maps to visualize continuous transitions among the SiCs. Diffusion maps have been shown to organize individual cells according to their intrinsic stemness, while maintaining the global structure of cell-to-cell similarities. The diffusion map representation was generated using the R package destiny (Angerer et al., 2015) .
In contrast to diffusion maps, PCA only captures linear effects. While this can result in reduced resolution of cell-cell similarities, PCA representations have a direct interpretation as linear projections. We visualized the genes driving variability along principal components one and two by plotting the five genes with largest positive and negative loadings for each PC, respectively. Differential expression analysis and pathway enrichment Genes that were differentially expressed between stages were identified using the Wilcoxon rank sum test, testing each stage versus all other stages. p values were corrected for multiple testing and considered statistically significant at a false discovery rate of 10%. Gene ontology (GO) enrichment was performed for up-and downregulated genes separately using the R package topGO and the elim algorithm (Bioconductor).
In addition to GO enrichment of differentially expressed genes, we also performed a pathway analysis based on the continuous expression values of cells assigned to individual stages. We used CAMERA (Wu and Smyth, 2012) to test whether a set of genes annotated to pathways form WikiPathways (Kutmon et al., 2016) is highly ranked relative to other genes in terms of differential expression. CAMERA heavily penalizes inter-gene correlation within groups based on the assumption it is not biologically relevant. However, this assumption does not hold for single-cell data where cells originate from a continuous biological process. As cells within the individual stages defined in our study are sampled from the continuous transition from dHSCs to active HSCs, even cells within stages can be ordered according to their intrinsic position on this trajectory. Consequently, we expect biologically relevant inter-gene correlations within each stage to remain and do not account for this inter-gene correlation.
To further explore additional gene signatures that have been reported to play a role in cell-cell-variability of HSCs, we assessed variability associated with a cell-cycle signature (Ashburner et al., 2000) and the recently described MolO signature (Wilson et al., 2015) . We performed a PCA on the genes annotated to either gene signature, and visualized variation along the first principal component to identify differences in cell state related to each signature. Pseudo-temporal analysis We reconstructed the pseudo-temporal order of all HSCs and dHSCs by measuring transitions between cells using diffusion-like random walks (Haghverdi et al., 2016) . We used the R package destiny to calculate diffusion pseudotime and visualized it in a diffusion map. We grouped cells into four stages in diffusion pseudo time by thresholding the inferred diffusion pseudo time at the 25%, 50% and 75% quantiles. To gain confidence that these stages were robust with respect to our normalization strategy, we repeated the same analysis using expression profiles that were size-factor normalized, resulting in robust stages ( Figures 2B, S2B, and S2C) .
We further assessed whether pathway activity changed significantly with pseudotime and performed a PCA on the genes annotated to a pathway from Wikipathways. Similar to the cell cycle analysis we used the first principal component to capture variation in cell states relative to individual pathways (pathway factors). We then tested for associations of the pathway activity with pseudotime. To this end, we modeled changes in pathway activity as a function of diffusion pseudotime by fitting a natural spline through the pathway factors using the Monocle package (Trapnell et al., 2014) .
post-transplantation and 3x10
6 cells were re-transplanted into irradiated (1 3 200 rad) NSG (CD45.1) recipient mice. Multipotency. 16-weeks after the 1 st transplant, peripheral blood of transplanted animals was stained with the following monoclonal antibodies:
anti-CD45.1 (A20)-PECy7, anti-CD45.2 (104)-PB, anti-CD11b (M1/70)-AF700, anti-GR1 (RB6.8C5)-APC-Cy7, anti-CD8a (53.6.7)-PE, anti-CD4 (GK1.5)-PE, anti-B220 (RA3.6B2)-PE-Cy5. Total myeloid, B-and T cells numbers were normalized to 100% as described (Cabezas-Wallscheid et al., 2014) . Cell cycle analysis HSC surface staining defined as (LSK CD150+ CD48-CD34-EGFP pos / neg ) was performed on Gprc5c-EGFP bone marrow cells. Cells were fixed with BD Cytofix/Cytoperm Buffer (Beckton Dickinson). Subsequently, intracellular Ki-67 (BD Biosciences) staining was performed using PermWash solution (Beckton Dickinson). Prior to flow cytometry analysis cells were stained with Hoechst 33342 (Invitrogen).
ATRA in vitro experiments Enrichment HSPCs
To enrich HSPCs for in vitro assays, lineage marker (CD4, CD8a, B220, Gr-1, CD11b, Ter119)-positive and CD48-positive cells were depleted from bone marrow using biotin-labeled antibodies and biotin binder streptavidin Dynabeads (Invitrogen). For bone marrow preparation, see above.
HSPCs plating and treatment
HSPCs from SCL-tTA;H2B-GFP, Gprc5c-EGFP, Myc-GFP and Mito-roGFP2-Orp1 mice were cultured in Complete Stem Cell Medium (StemPro-34 SFM, LifeTechnologies containing 50 ng/ml SCF, 25 ng/ml TPO, 30 ng/ml Flt3-Ligand (all Preprotech), 100 u/ml Penicillin/Streptomycin, 2 mM L-Glutamine). Cells were cultured in 6-well ultralow attachment plates and were treated with either ATRA (Sigma-Aldrich) (5 mM), Retinol (Sigma-Aldrich) (10 mM) or Myc inhibitor (Calbiochem) (53.3 mM) or the respective amount of DMSO. Colony-Forming-Unit assays (CFUs) of ATRA treated cells 1,000 FACS-sorted LSK cells from 8-12-week-old mice or 400 FACS-sorted HSC-Gpr pos/neg cells were FACS sorted and cultured in 100 ml Complete Stem Cell Medium (described in HSPCs Plating and Treatment) in 96 well ultra-low attachment plates and immediately treated with ATRA (5 mM) or the respective amount of DMSO. 72h after treatment, all cells of one well were harvested and cultured in MethoCult M3434 (StemCell Technologies). 9 Days after plating of CFUs, colony formation was quantified. 30,000 cells of each replicate were used for replating and cultured in MethoCult M3434 (StemCell Technologies). 5 days after replating, colonies were quantified. Serial transplantation experiments of ATRA treated cells 1,000 LSK cells from 8-12-week-old mice were FACS sorted and cultured in 100 ml Complete Stem Cell Medium (described in HSPCs Plating and Treatment) in 96 well ultra-low attachment plates and immediately treated with ATRA (5 mM) or the respective amount of DMSO. 72h after treatment, all cells of one well were harvested and transplanted into fully irradiated (2 3 4.5 Gy.) B6 mice (CD45.1) together with 1x10 5 supportive whole BM cells (CD45.1/2). Contribution of CD45.2-donor cells was monitored in peripheral blood at 4, 8, 12 and 16 weeks' post-transplantation in primary and secondary recipients ( Figure 4L ). Outcome was addressed by flow cytometry using the following monoclonal antibodies: anti-CD45.1 (A20)-PECy7; anti-CD45.2 (104)-PB. For secondary transplantations, whole BM was isolated 16 weeks post-transplantation and 3x10 6 cells were re-transplanted into fully irradiated (2 3 4.5 Gy.) B6 mice (CD45.1). HSCs-Gpr pos/neg and treatment 500 FACS-sorted HSCs-Gpr pos/neg from 6-month old Gprc5c-EGFP mice were cultured in Complete Stem Cell Medium (StemPro-34 SFM, LifeTechnologies containing 50 ng/ml SCF, 25 ng/ml TPO, 30 ng/ml Flt3-Ligand (all Preprotech), 100 u/ml Penicillin/Streptomycin, 2 mM L-Glutamine). Cells were cultured in 96-well ultralow attachment plates and were treated with either ATRA (Sigma-Aldrich) (10 mM), Retinol (10 mM) or the respective amount of DMSO for 24h. Caspase-3 staining For active Caspase 3 staining, cells were fixed and permeabilized using Cytofix/Cytoperm (Beckton Dickinson) after surface staining (LSK CD150+ CD48-CD34-). Intracellular staining with the anti-active Caspase 3-PE antibody (BD PharMingen) was performed over night at 4 C in PermWash solution (Beckton Dickinson). OP-Puro measurement Analysis of OP-Puro Incorporation using the Click-iT Technology. To measure protein synthesis, in vitro ATRA/DMSO-cultured HSPCs (described in HSPCs Plating and Treatment) were incubated for 1h in medium supplemented with O-propargyl-puromycin (OP-Puro) (Jena Biosciences, 50 mM final concentration). After harvesting, cells were surface-stained to enable specific analysis of LSK CD48-CD34-cells. Subsequently, the cells were fixed for 15 min at 4 C in PBS supplemented with 4% paraformaldehyde (Electron Microscopy Sciences, 19208) and then permeabilized in PBS supplemented with 1% bovine serum albumin (BSA) and 0.1% saponin by performing two washing steps. The copper-catalyzed azide-alkyne cycloaddition (CuAAC) was performed using an Alexa647-azide (Life Technologies, 5 mM final concentration) and the Click-iT Cell Reaction Buffer Kit (Life Technologies) according to the manufacturer's instructions.
ROS measurement
The Mito-roGFP2-Orp1 probe allows the qualitative measurement of H 2 O 2 levels in mitochondrial matrix of intact living cells (Fujikawa et al., 2016) . Fluorescence ratios (405/488 nm) were measured using a fluorescence microplate reader (PHERAstar FS, BMG Labtech) employing 10 5 enriched HSPCs expressing mito-roGFP2-Orp1 either freshly isolated (0h), in vitro DMSO-cultured (24h, Control) or ATRA-cultured cells (24h, ATRA; described in HSPCs Plating and Treatment). As control, samples were treated with 2mM diamide (Sigma-Aldrich) (fully oxidized) and 10 mM DTT (Applichem) (fully reduced). 405/488 nm raw ratio values were converted to OxD values as previously described (Meyer and Dick, 2010) . Gene expression of in vitro ATRA treated HSCs by microarray analysis A total of 4-5 mice were pooled for each replicate. Total of 3 replicates per condition, in 3 independent sorts. Enriched HSPCs from C57BL/6 J wild-type mice were cultured in Complete Stem Cell Medium as described above. 24 hr later, 10,000 HSCs were FACS sorted into RNA lysis buffer. HSC surface staining defined as LSK CD150
À . Total RNA was isolated as described above.
Vitamin A free diet Vitamin A free diet in homeostatic settings 3-4-week old mice were put in a vitamin A free diet (Altromin International GmbH & Co) for 14 to 17 weeks (N = 12). Littermate controls were fed with regular food and analyzed the same day (N = 9). 2 independent experiments. Peripheral blood analysis Peripheral blood counts were analyzed using the HEMAVET 1700 device according to manufacturer's instructions (Drew Scientific Group). Analysis of bone marrow differentiated cells 5x10 6 bone marrow cells from mice kept in vitamin A free diet and regular diet were stained with the following monoclonal antibodies:
anti-CD11b (M1/70)-APC-Cy7, anti-GR1 (RB6.8C5)-APC, anti-CD8a (53.6.7)-PB, anti-CD4(GK1.5)-PB, anti-B220 (RA3.6B2)-AF700, IgM(II-41)-PECy5, CD71(R17217)-PE. Total myeloid, B-and T cells outcome was normalized to 100% as described (Cabezas-Wallscheid et al., 2014) . Serial Colony-Forming-Unit assays (CFU)s of Vitamin A free diet BM cells 4x10 4 whole bone marrow cells from mice kept in vitamin A free diet and regular diet were cultured in MethoCult M3434 (StemCell Technologies). 7 Days after plating of CFUs, colony formation was quantified. In each plating: 30,000 cells of each replicate were used for 2 nd , 3 rd and 4 th plating and cultured in MethoCult M3434 (StemCell Technologies). 7, 5 and 5 days after replating respectively, colonies were quantified. Transplantation experiments of vitamin A free diet cells 2x10 5 whole bone marrow cells from C57BL/6 J wild-type mice kept on a vitamin A free diet for 14 weeks or on a regular diet were transplanted into fully irradiated (2 3 4.5 Gy.) CD45.1/2 mice in competition to 2x10 5 whole bone marrow cells from 4-5-month old CD45.1 mice (same age as competitor) within 24h after irradiation by tail vein injection. As quality control, contribution of CD45. mice were pooled for each replicate. Total of 3 replicates per condition. Total RNA was isolated and qPCR was performed as described above. Vitamin A free diet in reversibility experiments 3 to 4-week old mice were put on a vitamin A free diet for 14 weeks (N = 10). Littermate controls were fed with regular food and analyzed the same day (N = 8). 8-11 days before endpoint analysis mice were injected intraperitoneally with 50 mg Poly(I:C) or PBS alone. Of note, in each group 20% of mice were kept in vitamin A free diet or regular diet as control. 2 independent experiments.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis was performed by unpaired Student's t test or two-or one-way ANOVA without correction for multiple comparison (Fisher LSD test). All data are presented as mean ± SEM. Significance levels were set at p* < 0.05, p** < 0.01 and p*** < 0.001. For statistical analysis GraphPad Prism was used.
DATA AND SOFTWARE AVAILABILITY
The accession number for the population RNA-seq data of dHSCs, aHSCs, and MPP1 reported in this paper is ArrayExpress: E-MTAB-4549. The accession number for the single-cell RNA-seq data of dHSCs and HSCs reported in this paper is ArrayExpress: E-MTAB-4547. The accession number for the microarray data of in vitro and in vivo treatment with ATRA reported in this paper is GEO: GSE87814. A detailed description of data analyses and software used for each section can be found in METHODS DETAILS.
